SavedAdd your journal

Journals / Acta Medica / 2019 / Cilt: 50 - Sayı: 2

The Effect of Erythropoietin Treatment on Gene Expression Profile of Mesenchymal Stem Cells

Dilara DALKİRAN
BEREN KARAOSMANOĞLU
Ekim Z. TASKİRAN
Pages
16–24
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It will be important to perform further studies with in vitro models, mimicking different physiological conditions and diseases for Mesenchymal Stem Cells and exosome biology.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Mesenchymal Stem Cells are one of the most important elements of bone marrow microenvironment, which has a role in stromal support and stem cell differentiation.
📊
Key Findings & Data:Materials and Methods: Effect of 3 different doses of Erythropoietin (1 IU/ml, 10 IU/ml and 100 IU/ml) for 48 hours on Mesenchymal Stem Cells transcriptome profile was analyzed.
💡
Conclusion & Impact:It will be important to perform further studies with in vitro models, mimicking different physiological conditions and diseases for Mesenchymal Stem Cells and exosome biology.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: Mesenchymal Stem Cells are one of the most important elements of bone marrow microenvironment, which has a role in stromal support and stem cell differentiation. Exosomes are small vesicles that responsible from various cellular roles such as cell-cell communication and cell signaling, which may affect nearby and distant cells/tissues. Mesenchymal Stem Cells have therapeutic importance because of their multipotency and immune modulation potentials also with their exosomes. Erythropoietin, produced by liver hepatocytes, is responsible for erythroid differenti-ation (erythropoiesis) in bone marrow. In addition, Erythropoietin treatment of sev-eral cell types including Mesenchymal Stem Cells, showed therapeutic effects in var-ious diseases. Objective: The aim of this study is to examine the effect of erythropoietin on bone marrow Mesenchymal Stem Cells transcriptome and exosome derived miRNA profile. Materials and Methods: Effect of 3 different doses of Erythropoietin (1 IU/ml, 10 IU/ml and 100 IU/ml) for 48 hours on Mesenchymal Stem Cells transcriptome profile was analyzed. The results illustrated that 10 IU/ml Erythropoietin treatment has the most effective concentration in terms of gene expression profile. Therefore, small RNA libraries targeting miRNA was analyzed with 10 IU/ml Erythropoietin treated versus non treated groups with next generation sequencing. Results: We found that Erythropoietin treatment slightly changed global gene ex-pression profile. On the other hand, it was observed that Erythropoietin treated Mesenchymal Stem Cells have different exosomal miRNA profile. Conclusion: Differentially expressed exosomal miRNAs may have therapeutic effects in different conditions. It will be important to perform further studies with in vitro models, mimicking different physiological conditions and diseases for Mesenchymal Stem Cells and exosome biology.

🔖

Cite This Article

DALKİRAN, D., KARAOSMANOĞLU, B., TASKİRAN, E. Z. (2019). The Effect of Erythropoietin Treatment on Gene Expression Profile of Mesenchymal Stem Cells. Acta Medica, Cilt: 50 - Sayı: 2, 16–24. https://ajindex.com/articles/143131

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Kobolak J, Dinnyes A, Memic A, et al. Mesenchymal stem cells: Identification, phenotypic characterization, biolog-ical properties and potential for regenerative medicine through biomaterial micro-engineering of their niche. Methods 2016; 99: 62-8.
  2. Spees JL, Lee RH, Gregory CA. Mechanisms of mesenchy-mal stem/stromal cell function. Stem Cell Res Ther 2016; 7(1): 12 5. Vizoso FJ, Eiro N, Cid S, et al. Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine. Int J Mol Sci. 2017; 18(9). Thery C, Ostrowski M, Segura E. Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 2009; 9(8): 581-93.
  3. Zhang H-G, Grizzle WE. Exosomes: A Novel Pathway of Local and Distant Intercellular Communication that Facilitates the Growth and Metastasis of Neoplastic Lesions. The American Journal of Pathology 2014; 184(1): 28 - 41. Ophelders DR, Wolfs TG, Jellema RK, et al. Mesenchymal Stromal Cell-Derived Extracellular Vesicles Protect the Fetal Brain After Hypoxia-Ischemia. Stem Cells Transl Med 2016; 5(6): 754-63.
  4. Collino F, Bruno S, Incarnato D, et al. AKI Recovery Induced by Mesenchymal Stromal Cell-Derived Extracellular Vesicles Carrying MicroRNAs. J Am Soc Nephrol 2015; 26(10): 2349-60.
  5. Jarmalaviciute A, Pivoriunas A. Exosomes as a poten-tial novel therapeutic tools against neurodegenerative diseases. Pharmacol Res 2016; 113(Pt B): 816-22
  6. Tomasoni S, Longaretti L, Rota C, et al. Transfer of growth factor receptor mRNA via exosomes unravels the regen-erative effect of mesenchymal stem cells. Stem Cells Dev 2013; 22(5): 772-80.
  7. Phinney DG, Pittenger MF. Concise Review: MSC-Derived Exosomes for Cell-Free Therapy. Stem Cells 2017; 35(4): 851- 8. Miyake T, Kung CK, Goldwasser E. Purification of human erythropoietin. J Biol Chem 1977; 252(15): 5558-64.
  8. Onal EM, Sag AA, Sal O, et al. Erythropoietin mediates brain-vascular-kidney crosstalk and may be a treatment target for pulmonary and resistant essential hyperten-sion. Clin Exp Hypertens 2017; 39(3): 197-209.
  9. Powell JS, Berkner KL, Lebo RV, et al. Human erythropoie-tin gene: high level expression in stably transfected mam-malian cells and chromosome localization. Proc Natl Acad Sci USA 1986; 83(17): 6465-9.
  10. Noguchi CT, Wang L, Rogers HM, el at. Survival and prolif-erative roles of erythropoietin beyond the erythroid lin-eage. Expert Rev Mol Med 2008; 10: e36. Maiese K, Li F, Chong ZZ. New avenues of exploration for erythropoietin. JAMA 2005; 293(1): 90-5.
  11. Li J, Guo W, Xiong M, e